FDA approves first new drug for ALS in 2 decades

After nearly two decades FDA has finally approved a drug for the treatment of amyotrophic lateral sclerosis (ALS). The d...

May 11, 2017 | Thursday | News
A new drug for diabetes

Indian scientists have found that a plant-derived substance called chalcone can be used to make an effective anti-diabet...

May 2, 2017 | Tuesday | News
Foamix Pharmaceuticals Ltd. completed Phase 3 trials for FMX101

Foamix Pharmaceuticals Ltd., a clinical stage specialty pharmaceutical company focused on developing and commercializing...

May 2, 2017 | Tuesday | News
Novel antibiotic resistance gene found in milk

According to the new study conducted by researchers of the University of Bern in Switzerland 'harmless' bacteria found i...

May 1, 2017 | Monday | News
Glenmark initiates clinical investigation for respiratory drug

Global pharmaceutical major Glenmark Pharmaceuticals has received the US Food and Drug Administration (USFDA) approval f...

April 28, 2017 | Friday | News
Asceneuron gets regulatory approval to initiate clinical trial of new drug candidate

Singapore: Asceneuron, an emerging leader in the development of innovative small molecules for neurodegenerative disease...

April 7, 2017 | Friday | News
Licensing agreement announced for sutezolid drug for TB

TB Alliance and Medicines Patent Pool announced a licensing agreement for the clinical development of sutezolid. It is a...

March 24, 2017 | Friday | News
Astex Pharma cancer drug receives US marketing approval

Astex Pharmaceuticals, a pharmaceutical company dedicated to the discovery and development of novel small molecule thera...

March 14, 2017 | Tuesday | News
Chugai receives Taiwan nod for Alecensa

Singapore: Japan's leading pharma giant Chugai pharmaceuticals announced that its subsidiary Chugai Pharma Taiwan has re...

February 27, 2017 | Monday | News
TimeBlock - to reverse biological ageing launches in Singapore

For thousands of years, humans have been on a quest to combat the process of degenerative ageing and find the secret of ...

February 20, 2017 | Monday | News
Australia approves drug that can 'melt away' cancer cells

Singapore: Australian authorities have just approved a new drugvenetoclax that is touted to have the power to "melt away...

January 10, 2017 | Tuesday | News
Boehringer Ingelheim bevacizumab biosimilar candidate demonstrates bioequivalence to Avastin

Boehringer Ingelheim announced new data from the Phase I INVICTAN-1 study, which show that BI 695502, its bevacizumab bi...

November 23, 2016 | Wednesday | News
NUS scientists discover the switch that makes breast cancer cells aggressive

Singapore: A team of scientists from National University of Singapore (NUS) has established novel insights into the rel...

November 2, 2016 | Wednesday | News
"Prevalence of COPD in Asia is similar to western countries"

GlaxoSmithKline and biopharmaceutical company, Innoviva, have concluded Salford Lung Study (SLS), a Phase IIIb multi-cen...

October 27, 2016 | Thursday | Influencers
Singapore develops oral-anti-diabetic drug

Singapore: Singapore has completed phase I clinical trial of an oral-anti-diabetic drug developed by Department of Pharm...

October 21, 2016 | Friday | News
South Korea's Hanmi pharmaceuticals in troubled waters!

Singapore: New blockbuster cancer drug from South Korea's Hanmi pharmaceuticals is in troubled waters after a patient di...

October 14, 2016 | Friday | News
"We are looking to collaborate with visionary research institutes to develop new methods of discovering cancer"

Singapore: Waters Corporation recently collaborated with Bioprocessing Technology Institute (BTI), a research institute ...

October 4, 2016 | Tuesday | Influencers
Renowned neurologist, Allen Roses, passes away

Singapore: Allen David Roses, a renowned neurologist who pioneered breakthrough research in Alzhiemer's Disease, passed ...

October 5, 2016 | Wednesday | Influencers

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls